Roger J. Smith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Roger J. Smith has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- John D. Santamaria
St Vincent's Hospital Melbourne, 41 Victoria Parade, Fitzroy, VIC 3065, Australia
6 shared publications - David A. Reid
University of Agder
3 shared publications David A. Reid
Department of Critical Care Medicine, St Vincent's Hospital, Melbourne, Victoria, Australia
2 shared publications- David A. Reid
Department of Critical Care Medicine St Vincent’s Hospital Melbourne Victoria Australia
2 shared publications Espedito E. Faraone
Department of Critical Care Medicine, St Vincent's Hospital, Melbourne, Victoria, Australia
2 shared publicationsJennifer A. Holmes
Department of Critical Care Medicine, St Vincent's Hospital, Melbourne, Victoria, Australia
2 shared publications
Latest Publications
- 27 March 2025
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 53 (4) , 238-252
A randomised, open-label trial of nebulised unfractionated heparin in patients mechanically ventilated for COVID-19
Nebulised unfractionated heparin (UFH) might reduce time to ventilator separation in patients with COVID-19 by reducing virus infectivity, pulmonary coagulopathy, and inflammation, but clinical trial data are limited. Between 1 July 2020 and 23 March 2022, we conducted, at two hospitals in Victoria, Australia, a randomised, parallel-group, open-label, controlled trial of nebulised UFH. Eligible patients were aged 18 years or more, intubated, under intensive care unit management, had a P a O 2 to F I O 2 ratio of 300 or less, had acute opacities affecting at least one lung quadrant and attributed to COVID-19, and were polymerase chain reaction-positive for SARS-CoV-2 or had further testing planned. The target sample size was 270, however, the trial was stopped due to slow recruitment. There were 50 enrolments, all of whom were analysed. The median age was 55 (interquartile range (IQR) 46–64) years, 28 (56%) were males, and 46 (92%) had acute respiratory distress syndrome. Twenty-seven (54%) were randomised to nebulised heparin and 23 (46%) to standard care. Nebulised UFH was administered to the heparin group on 6 (IQR 4–10) days; median daily dose of 83 (IQR 75–88) kIU. The primary outcome, time to separation from invasive ventilation to day 28 adjusted for the competing risk of death, was not significantly different between groups but took numerically longer in the nebulised heparin group (12.0, standard deviation (SD) 10.4 days versus 7.4, SD 6.9 days; hazard ratio (HR) 0.56, 95% confidence interval (CI) 0.31 to 1.01, P = 0.052). One patient died by day 28 in each group, fewer than expected. Time to separation from invasive ventilation among survivors to day 28 occurred more quickly than expected in the standard care group and was, without correction for multiple comparisons, significantly slower in the heparin group (11.3, SD 10.0 days, n = 26 versus 6.4, SD 5.2 days, n = 22; HR 0.52, 95% CI 0.30 to 0.92, P = 0.024). Nebulised heparin did not reduce time to ventilator separation in intubated adult patients with COVID-19. The study is limited by the small sample size and potential for sampling bias. Further study is required.
- 27 March 2025
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 53 (4) , 238-252
A randomised, open-label trial of nebulised unfractionated heparin in patients mechanically ventilated for COVID-19
Nebulised unfractionated heparin (UFH) might reduce time to ventilator separation in patients with COVID-19 by reducing virus infectivity, pulmonary coagulopathy, and inflammation, but clinical trial data are limited. Between 1 July 2020 and 23 March 2022, we conducted, at two hospitals in Victoria, Australia, a randomised, parallel-group, open-label, controlled trial of nebulised UFH. Eligible patients were aged 18 years or more, intubated, under intensive care unit management, had a P a O 2 to F I O 2 ratio of 300 or less, had acute opacities affecting at least one lung quadrant and attributed to COVID-19, and were polymerase chain reaction-positive for SARS-CoV-2 or had further testing planned. The target sample size was 270, however, the trial was stopped due to slow recruitment. There were 50 enrolments, all of whom were analysed. The median age was 55 (interquartile range (IQR) 46–64) years, 28 (56%) were males, and 46 (92%) had acute respiratory distress syndrome. Twenty-seven (54%) were randomised to nebulised heparin and 23 (46%) to standard care. Nebulised UFH was administered to the heparin group on 6 (IQR 4–10) days; median daily dose of 83 (IQR 75–88) kIU. The primary outcome, time to separation from invasive ventilation to day 28 adjusted for the competing risk of death, was not significantly different between groups but took numerically longer in the nebulised heparin group (12.0, standard deviation (SD) 10.4 days versus 7.4, SD 6.9 days; hazard ratio (HR) 0.56, 95% confidence interval (CI) 0.31 to 1.01, P = 0.052). One patient died by day 28 in each group, fewer than expected. Time to separation from invasive ventilation among survivors to day 28 occurred more quickly than expected in the standard care group and was, without correction for multiple comparisons, significantly slower in the heparin group (11.3, SD 10.0 days, n = 26 versus 6.4, SD 5.2 days, n = 22; HR 0.52, 95% CI 0.30 to 0.92, P = 0.024). Nebulised heparin did not reduce time to ventilator separation in intubated adult patients with COVID-19. The study is limited by the small sample size and potential for sampling bias. Further study is required.
- 1 January 2019
- Published by Elsevier in Australian Critical Care
- Vol. 32, S17
Hospital Admission Characteristics are Associated with Hospital Discharge Outcomes After in-Hospital Arrest
- 1 January 2019
- Published by Elsevier in Australian Critical Care
- Vol. 32, S17
Hospital Admission Characteristics are Associated with Hospital Discharge Outcomes After in-Hospital Arrest
- 8 November 2018
- Published by Wiley in Internal Medicine Journal
- Vol. 49 (8) , 978-985
Frailty is associated with reduced prospect of discharge home after in‐hospital cardiac arrest
Background: Frailty is common among acute hospital patients and might adversely affect recovery from inpatient cardiac arrest. Aim: To assess the relationship between hospital admission characteristics, including frailty, and discharge outcome after in‐hospital cardiac arrest. Methods: Prospectively collected data were retrospectively analysed for all separations from a tertiary hospital during 2008–2017 that involved rapid response team attendance for cardiac arrest. Hospital Frailty Risk Score (HFRS) and Charlson index of comorbidity were calculated from ‘primary’ and ‘associated’ International Classification of Diseases, 10th revision, Australian Modification diagnoses. HFRS ≥5 was taken to signify frailty. Discharge home from hospital and death in hospital were modelled using logistic regression. Results: There were 388 in‐hospital arrest patients: 91% were aged ≥50 years, 34% were previously discharged in the past 6 months, 66% were unplanned admissions, 63% were non‐cardiology‐cardiothoracic admissions, 45% had a Charlson comorbidity index ≥2 and 19% were identified as frail. Discharge home occurred in 22%, discharge to another hospital 17% and death 62%. Of the frail patients, only 3 (4%) were discharged home, 12 (17%) were discharged to another hospital and 57 (79%) died in hospital. Fewer frail patients were discharged home compared with non‐frail patients (4 vs 26%; odds ratio (OR) 0.13, P = 0.001). On multivariable analysis, patients were less likely to be discharged home if they had frailty (OR 0.24, P = 0.02), age ≥ 50 years (OR 0.36, P = 0.01), non‐cardiology‐cardiothoracic unit admission (OR 0.40, P = 0.001) and unplanned admission (OR 0.57, P = 0.04). Frail patients discharged to another hospital spent a median of 15 days (interquartile range 11–23) in the hospital post‐arrest before leaving to continue inpatient care elsewhere. Frailty was associated with death in hospital on univariate analysis (79 vs 58%; OR 2.80, P = 0.001) but not after controlling for other factors. Conclusion: Frail patients are unlikely to make a good recovery after in‐hospital arrest. This should be taken into account when planning care with patients and their families.
- 8 November 2018
- Published by Wiley in Internal Medicine Journal
- Vol. 49 (8) , 978-985
Frailty is associated with reduced prospect of discharge home after in‐hospital cardiac arrest
Background: Frailty is common among acute hospital patients and might adversely affect recovery from inpatient cardiac arrest. Aim: To assess the relationship between hospital admission characteristics, including frailty, and discharge outcome after in‐hospital cardiac arrest. Methods: Prospectively collected data were retrospectively analysed for all separations from a tertiary hospital during 2008–2017 that involved rapid response team attendance for cardiac arrest. Hospital Frailty Risk Score (HFRS) and Charlson index of comorbidity were calculated from ‘primary’ and ‘associated’ International Classification of Diseases, 10th revision, Australian Modification diagnoses. HFRS ≥5 was taken to signify frailty. Discharge home from hospital and death in hospital were modelled using logistic regression. Results: There were 388 in‐hospital arrest patients: 91% were aged ≥50 years, 34% were previously discharged in the past 6 months, 66% were unplanned admissions, 63% were non‐cardiology‐cardiothoracic admissions, 45% had a Charlson comorbidity index ≥2 and 19% were identified as frail. Discharge home occurred in 22%, discharge to another hospital 17% and death 62%. Of the frail patients, only 3 (4%) were discharged home, 12 (17%) were discharged to another hospital and 57 (79%) died in hospital. Fewer frail patients were discharged home compared with non‐frail patients (4 vs 26%; odds ratio (OR) 0.13, P = 0.001). On multivariable analysis, patients were less likely to be discharged home if they had frailty (OR 0.24, P = 0.02), age ≥ 50 years (OR 0.36, P = 0.01), non‐cardiology‐cardiothoracic unit admission (OR 0.40, P = 0.001) and unplanned admission (OR 0.57, P = 0.04). Frail patients discharged to another hospital spent a median of 15 days (interquartile range 11–23) in the hospital post‐arrest before leaving to continue inpatient care elsewhere. Frailty was associated with death in hospital on univariate analysis (79 vs 58%; OR 2.80, P = 0.001) but not after controlling for other factors. Conclusion: Frail patients are unlikely to make a good recovery after in‐hospital arrest. This should be taken into account when planning care with patients and their families.
- 4 July 2017
- Published by Wiley in Internal Medicine Journal
- Vol. 47 (7) , 767-774
Use of resuscitation plans at a tertiary Australian hospital: room for improvement
Background: The ‘Acute Resuscitation Plan’ (ARP) is a document for recording the resuscitation plans of patients at a tertiary hospital for adult patients. The ARP was introduced at the hospital in September 2014, superseding the ‘Not for Cardiopulmonary Resuscitation (CPR)’ form. Unlike the Not for CPR form, the ARP was relevant to patients with and without resuscitation limits.Aim: To evaluate the introduction of the ARP.Methods: This study is a retrospective audit of the records of all admissions to the hospital from January to June 2014 (Not for CPR period) and January to June 2015 (ARP period). The main outcomes are the incidence of resuscitation plans, the proportion of ARP specifying consultation with the patient (or representative) and with senior medical staff, and the proportion of ARP among older patients and those with significant comorbidity.Results: Resuscitation plans were present for 453 of 23 325 (1.9%) admissions in the Not for CPR period versus 1801 of 24 037 (7.5%) in the ARP period (odds ratio (OR) 4.1, 95% confidence interval (CI) 3.7–4.5, P < 0.001). A total of 42% of ARP specified ‘care of the dying’ in the event of arrest. Acknowledgement of the views of the patient (or representative) was indicated on 37% of ARP and of a senior physician on 28%. An ARP was not present for 67% of patients aged ≥90 years, 59% from aged care, 90% with metastatic cancer and 64% aged ≥80 years and with a Charlson comorbidity index ≥3.Conclusions: More patients had resuscitation plans after introducing the ARP. However, patients and senior physicians were often remote from the consultation process, and an ARP was not present for many patients likely to have a poor outcome from cardiopulmonary arrest.
- 4 July 2017
- Published by Wiley in Internal Medicine Journal
- Vol. 47 (7) , 767-774
Use of resuscitation plans at a tertiary Australian hospital: room for improvement
Background: The ‘Acute Resuscitation Plan’ (ARP) is a document for recording the resuscitation plans of patients at a tertiary hospital for adult patients. The ARP was introduced at the hospital in September 2014, superseding the ‘Not for Cardiopulmonary Resuscitation (CPR)’ form. Unlike the Not for CPR form, the ARP was relevant to patients with and without resuscitation limits.Aim: To evaluate the introduction of the ARP.Methods: This study is a retrospective audit of the records of all admissions to the hospital from January to June 2014 (Not for CPR period) and January to June 2015 (ARP period). The main outcomes are the incidence of resuscitation plans, the proportion of ARP specifying consultation with the patient (or representative) and with senior medical staff, and the proportion of ARP among older patients and those with significant comorbidity.Results: Resuscitation plans were present for 453 of 23 325 (1.9%) admissions in the Not for CPR period versus 1801 of 24 037 (7.5%) in the ARP period (odds ratio (OR) 4.1, 95% confidence interval (CI) 3.7–4.5, P < 0.001). A total of 42% of ARP specified ‘care of the dying’ in the event of arrest. Acknowledgement of the views of the patient (or representative) was indicated on 37% of ARP and of a senior physician on 28%. An ARP was not present for 67% of patients aged ≥90 years, 59% from aged care, 90% with metastatic cancer and 64% aged ≥80 years and with a Charlson comorbidity index ≥3.Conclusions: More patients had resuscitation plans after introducing the ARP. However, patients and senior physicians were often remote from the consultation process, and an ARP was not present for many patients likely to have a poor outcome from cardiopulmonary arrest.
- Open Access
- 1 March 2017
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 19 (1) , 71-80.e4
Rapid response team diagnoses: frequencies and related hospital mortality
- 1 March 2017
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 19 (1) , 71-80.e4
Open AccessRapid response team diagnoses: frequencies and related hospital mortality
- 1 August 2015
- Published by Elsevier in Journal of Critical Care
- Vol. 30 (4) , 692-697
The duration of hospitalization before review by the rapid response team: A retrospective cohort study
- 1 August 2015
- Published by Elsevier in Journal of Critical Care
- Vol. 30 (4) , 692-697
The duration of hospitalization before review by the rapid response team: A retrospective cohort study
- 1 May 2013
- Published by Elsevier in Australian Critical Care
- Vol. 26 (2) , 85-86
Fluid therapy using bicarbonate-containing crystalloid solutions and acid–base stability after cardiac surgery
- 1 May 2013
- Published by Elsevier in Australian Critical Care
- Vol. 26 (2) , 85-86
Fluid therapy using bicarbonate-containing crystalloid solutions and acid–base stability after cardiac surgery